Oncoproteomics and Advanced Microfluidic and Mass Spectrometry Technologies
“The problems of chemistry and biology can be greatly helped if our ability to see what we are doing, and to do things on an atomic level, is ultimately developed, …” said Feynman in 1956. Today, at the dawn of the 21st century, human kind has reached this ability. In our laboratory, we seek the development of advanced proteomic, mass spectrometry and microfluidic technologies that will enable us “to see” at the molecular level and perform an in-depth exploration of biological systems. Core projects include oncoproteomics, breast cancer cell cycle, phospho-signaling, drug target and biomarker discovery, and lab-on a-chip applications.